Does the use of doxazosin influence the success of SWL in the treatment of upper ureteral stones? A multicenter, prospective and randomized study

Urological Research

Volumn 40, Issue 5, 2012, Pages 537-542

  Ateş, Ferhat ^a   Eryildirim, Bilal ^b   Öztürk, Metin Ishak ^c   Turan, Turgay ^d   Gürbüz, Cenk ^e   Ekinci, Mete Oǧuz ^d   Yildirm, Asif ^e   Göktaş, Cemal ^b   Şenkul, Temuçin ^a   Sarca, Kemal ^f  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b Dr Lutfi Kirdar Kartal Teaching and Research Hospital   (Turkey)

^c Haydarpasa Numune Teaching and Research Hospital   (Turkey)

^d Umraniye Teaching and Research Hospital   (Turkey)

^e Clinical Biochemistry Laboratory   (Turkey)

^f YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Doxazosin; SWL; Ureteral stone

Indexed keywords

ANALGESIC AGENT; DOXAZOSIN;

ADULT; ANALGESIA; ARTICLE; COLIC; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG USE; EXTRACORPOREAL LITHOTRIPSY; FEMALE; HUMAN; HYPOTENSION; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MULTICENTER STUDY; ORAL REHYDRATION THERAPY; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STEINSTRASSE; STONE CLEARANCE TIME; TABLET; TREATMENT OUTCOME; UPPER URETER STONE; URETER STONE;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADULT; DOXAZOSIN; FEMALE; HUMANS; LITHOTRIPSY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URETERAL CALCULI;

EID: 84867898005     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-011-0455-x     Document Type: Article

References (38)

1. Ramello A, Vitale C, Marangella M (2000) Epidemiology of nephrolithiasis. J Nephrol 13(Suppl 3):45-50
2. Chaussy C, Chaussy C, Schmiedt E, Jocham D, Brendel W, Forssmann B, Walther V (1982) First clinical experience with extracorporeally induced destruction of kidney stones by shock waves. J Urol 127:417-420
3. Preminger GM, Tiselius HG, Assimos DG et al (2007) 2007 Guideline for the management of ureteral calculi. Eur Urol 52:1610-1631
4. Kim FJ, Rice KR (2006) Prediction of shockwave failure in patients with urinary tract stones. Curr Opin Urol 16:88-92
5. Argyropoulos AN, Tolley DA (2007) Optimizing shock wave lithotripsy in the 21st century. Eur Urol 52:344-352
6. Hochreiter WW, Danuser H, Perrig M, Studer UE (2003) Extracorporeal shock wave lithotripsy for distal ureteral calculi: what a powerful machine can achieve. J Urol 169:878-880
7. Bouffioux CR, Penders L (1984) Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem. Eur Urol 10:306-310
8. Hollingsworth JM, Rogers MA, Kaufman SR et al (2006) Medical therapy to facilitate urinary stone passage: a metaanalysis. Lancet 368:1171-1179
9. Sterrett SP, Nakada SY (2008) Medical expulsive therapy. Curr Opin Urol 18:210-213
10. Michel MC, De La Rosette JJ (2006) Alphablocker treatment of urolithiasis. Eur Urol 50:213-214
11. Menon M, Resnick MI (2002) Urinary lithiasis: etiology, diagnosis and medical management. In: Walsh PC (ed) Campbell's urology. Saunders, Philadelphia, pp 3227-3229
12. Stoller ML, Bolton DM (2000) Urinary stone disease. In: Tanagho EA (ed) Smith's urology. Lange Medical Book/McGraw-Hill, San Francisco, pp 292-320
13. Miyatake R, Tomiyama Y, Murakami M et al (2001) Effects of isoproterenol and butylscopolamine on the friction between an artificial stone and the intraureteral wall in anesthetized rabbits. J Urol 166:1083-1087
14. Weiss RM (2002) Physiology and pharmacology of renal pelvis and ureter. In: Walsh PC (ed) Campbell's urology. Saunders, Philadelphia, pp 377-456
15. Sivula A, Lehtonen T (1967) Spontaneous passage of artificial concretions applied in the rabbit ureter. Scand J Urol Nephrol 1:259-263
16. Tiselius HG, Aronsen T, Bohgard S et al (2010) Is high diuresis an important prerequisite for successful SWL-disintegration of ureteral stones? Urol Res 38:143-146
17. Hancock AA (1996) a1 Adrenoceptor: a synopsis of their pharmacology and molecular biology. Drug Dev Res 39:54-107
18. Sigala S, Dellabella M, Milanese G et al (2004) Alpha1 adrenoceptor subtypes in men juxtavesical ureter: molecular and pharmacological characterization. Eur Urol 3(Suppl):119-122
19. Hieble JP, Caine M, Zalaznik E (1985) In vitro characterization of the alpha-adrenoceptors in human prostate. Eur J Pharmacol 107:111-117
20. Dellabella M, Milanese G, Muzzonigro G (2003) Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170:2202-2205
21. Porpiglia F, Ghignone G, Fiori C et al (2004) Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 172:568-571
22. Wang Huijun, Liu Ke, Ji Zhigang, Li Hanzhong (2010) Effect of a1-adrenergic antagonists on lower ureteral stones with extracorporeal shock wave lithotripsy. Asian J Surg 33(1):37-41
23. Sigala S, Dellabella M, Milanese G et al (2005) Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn 24:142-148
24. Liatsikos EN, Katsakiori PF, Assimakopoulos K, Voudoukis T, Kallidonis P, Constantinides C, Athanasopoulos A, Stolzenburg JU, Perimenis P (2007) Doxazosin for the management of distalureteral stones. J Endourol 21(5):538-541
25. Autorino R, De Sio M, Damiano R, Di Lorenzo G, Perdonà S, Russo A, Quarto G, Cosentino L, D'Armiento M (2005) The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand? Urol Res 33(6):460-464
26. Hermanns T, Sauermann P, Rufibach K, Frauenfelder T, Sulser T, Strebel RT (2009) Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial. Eur Urol 56(3):407-412
27. Zhu Y, Duijvesz D, Rovers MM, Lock TM (2009) Alphablockers to assist stone clearance after extracorporeal shock wave lithotripsy: a meta-analysis. BJU Int 106(2):256-261
28. Kobayashi M, Naya Y, Kino M et al (2008) Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone. Int J Urol 15:495-498
29. Zehri AA, Ather MH, Abbas F, Biyabani SR (2010) Preliminary study of efficacy of doxazosin as a medical expulsive therapy of distal ureteric stones in a randomized clinical trial. Urology 75(6):1285-1288
30. Ayubov B, Arustamov D, Mukhtarov S (2007) Efficacy of doxazosin in the management of ureteral stones. Eur Urol Suppl 6:114 (abstract 368)
31. Liatsikos EN, Katsakiori PF, Assimakopoulos K et al (2007) Doxazosin for the management of distal-ureteral stones. J Endourol 21:538-541
32. Mukhtarov S, Turdiev A, Fozilov A et al (2007) Using doxazosin for distal ureteral stone clearance with or without shock wave lithotripsy. Eur Urol Suppl 6:216 (abstract 774)
33. Ukhal MI, Malomuzh OI, Strashny V (1999) Administration of doxazosin for speedy elimination of stones from lower section of ureter. Eur Urol 35(Suppl 2):4-6
34. Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H (2005) The comparison and efficacy of 3 different a1-adrenergic blocker for distal ureteral stones. J Urol 173:2010-2012
35. Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U (2009) Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 56:455-471
36. Shaaban AM, Barsoum NM, Sagheer GA, Ahmed Z (2008) Is there a role for alpha blockers after SWL for renal and upper ureteral stones? J Urol 179:A1459
37. Lee SH, Park KK, Mah SY, Chung BH (2010) Effects of alpha blocker add on treatment on blood pressure in symptomatic BPH with or without concomitant hypertension. Prostate Cancer Prostatic Dis 13:333-337
38. Kirby RS, Andersen M, Gratzke P, Dahlstrand C, Hoye K (2001) A combined analysis of double blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia. BJU Int 87:192-200